Astrid Voigt

949 total citations
24 papers, 765 citations indexed

About

Astrid Voigt is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, Astrid Voigt has authored 24 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Astrid Voigt's work include Neuroblastoma Research and Treatments (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Acute Myeloid Leukemia Research (3 papers). Astrid Voigt is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Acute Myeloid Leukemia Research (3 papers). Astrid Voigt collaborates with scholars based in Germany, Switzerland and United States. Astrid Voigt's co-authors include F Zintl, Daniel Steinbach, Axel Sauerbrey, J Hermann, Bernd Gruhn, K Dawczynski, Ralf Häfer, Masanori Onda, Ira Pastan and Peter Hartmann and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Astrid Voigt

24 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Voigt Germany 14 393 393 104 102 93 24 765
Janice Madafiglio Australia 13 460 1.2× 361 0.9× 71 0.7× 37 0.4× 325 3.5× 18 800
DW Kufe United States 16 563 1.4× 223 0.6× 31 0.3× 124 1.2× 20 0.2× 31 884
Claudia L. Flemming Australia 15 604 1.5× 554 1.4× 66 0.6× 23 0.2× 344 3.7× 22 1.1k
Houda Alachkar United States 20 613 1.6× 192 0.5× 26 0.3× 190 1.9× 13 0.1× 60 1.0k
N. Lale Şatıroğlu-Tufan Türkiye 18 571 1.5× 191 0.5× 53 0.5× 19 0.2× 35 0.4× 42 997
Barbara Lamb United States 18 418 1.1× 80 0.2× 24 0.2× 25 0.2× 48 0.5× 27 633
Maria Braoudaki Greece 17 404 1.0× 86 0.2× 30 0.3× 89 0.9× 28 0.3× 49 787
Yanwen Zhou Japan 16 394 1.0× 158 0.4× 13 0.1× 49 0.5× 40 0.4× 34 618
Yan Xu China 17 563 1.4× 436 1.1× 26 0.3× 478 4.7× 20 0.2× 111 1.1k
Nitzan Gonen Israel 11 500 1.3× 130 0.3× 35 0.3× 36 0.4× 8 0.1× 17 801

Countries citing papers authored by Astrid Voigt

Since Specialization
Citations

This map shows the geographic impact of Astrid Voigt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Voigt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Voigt more than expected).

Fields of papers citing papers by Astrid Voigt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Voigt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Voigt. The network helps show where Astrid Voigt may publish in the future.

Co-authorship network of co-authors of Astrid Voigt

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Voigt. A scholar is included among the top collaborators of Astrid Voigt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Voigt. Astrid Voigt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marx, Christian, Frank Weise, Birgit Perner, et al.. (2020). Biomimetic reconstruction of the hematopoietic stem cell niche for in vitro amplification of human hematopoietic stem cells. PLoS ONE. 15(6). e0234638–e0234638. 11 indexed citations
2.
Beckmann, Christiane, et al.. (2019). Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell lines. European Journal of Gynaecological Oncology. 40(1). 106–112. 3 indexed citations
3.
Matuschek, Christiane, Edwin Bölke, Claus Belka, et al.. (2013). Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck. Strahlentherapie und Onkologie. 189(8). 625–631. 12 indexed citations
4.
Sonnemann, Jürgen, Chithra D. Palani, Susan Wittig, et al.. (2011). Anticancer effects of the p53 activator nutlin-3 in Ewing’s sarcoma cells. European Journal of Cancer. 47(9). 1432–1441. 36 indexed citations
5.
Junker, Kerstin, Marcus Franz, Petra Richter, et al.. (2011). B domain containing Tenascin-C: A new urine marker for surveillance of patients with urothelial carcinoma of the urinary bladder?. Clinica Chimica Acta. 412(21-22). 1931–1936. 10 indexed citations
6.
Berndt, Alexander, Petra Richter, Marcus Franz, et al.. (2010). A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies. Histochemistry and Cell Biology. 133(4). 467–475. 30 indexed citations
7.
König, Christian, Romina Marone, Luise Röpke, et al.. (2010). Targeting PI3K in neuroblastoma. Journal of Cancer Research and Clinical Oncology. 136(12). 1881–1890. 16 indexed citations
8.
Steinbach, Daniel, Masanori Onda, Astrid Voigt, et al.. (2007). Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells. European Journal Of Haematology. 79(4). 281–286. 26 indexed citations
10.
Steinbach, Daniel, Alexander Schramm, Angelika Eggert, et al.. (2006). Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia. Clinical Cancer Research. 12(8). 2434–2441. 103 indexed citations
11.
Voigt, Astrid, et al.. (2004). Conjugated linoleic acid modulation of cell membrane in leukemia cells. Cancer Letters. 209(1). 87–103. 39 indexed citations
12.
Steinbach, Daniel, et al.. (2003). Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia.. PubMed. 9(3). 1083–6. 46 indexed citations
13.
Voigt, Astrid & F Zintl. (2003). Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Medical and Pediatric Oncology. 40(4). 205–213. 52 indexed citations
15.
Steinbach, Daniel, et al.. (2002). BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia. 16(8). 1443–1447. 187 indexed citations
16.
Sauerbrey, Axel, et al.. (2002). Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia. British Journal of Haematology. 118(1). 147–150. 79 indexed citations
17.
Voigt, Astrid, Peter Hartmann, & F Zintl. (2000). Differentiation, Proliferation and Adhesion of Human Neuroblastoma Cells After Treatment with Retinoic Acid. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 7(5). 423–440. 37 indexed citations
18.
Voigt, Astrid, et al.. (1997). Radioimmunodetection of Neuroblastoma Cells with I-131-Radiolabelled Antibodies. Cancer Biotherapy and Radiopharmaceuticals. 12(3). 187–194. 2 indexed citations
20.
Voigt, Astrid, et al.. (1993). Monoclonal antibodies against neuroblastoma. Production and preliminary characterization of their specificity. Journal of Neuroimmunology. 43(1-2). 125–130. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026